Welcome to the second issue of ARV4IDUs.

We had a great response to Issue one, saying that it it was important and timely that at last a publication was focussed on the issues of antiretroviral treatment for injecting drug users.

For the second issue, along with coverage form the IAS meeting in Sydney, we’re fortunate to include three orginal articles.

Kora de Beck and Thomas Kerr look at the ARV treatment implication for IDUs in prison from a Canadian perspective.

Doug Bruce pulls together an important overview of the interactions between opiate withdrawal medication (methadone and buprenorphine) and ARVs.

Kon Lezhentsev and Larysa Badrieva write about the difficulties of HIV treatment in the Russian Federation, where there is no access to substitution treatment, and highlight an important project that is having success in this area.

We’d also like to encourage new writers who would like to contribute to future issues. This can include research reports and overview articles. If you would like to contribute to future issues or have news to include, please email:

ARV4IDUs@i-Base.org.uk

To subscribe, please register online.

ARV4IDUs is produced in English and Russian and is distributed by email and published on the i-Base website.

ARV4IDUs is produced as a supplement to the i-Base HIV Treatment Bulletin (HTB) and has been supported by a grant from the International Harm Reduction Development Program of the Open Society Institute (www.soros.org).